<DOC>
	<DOCNO>NCT01455558</DOCNO>
	<brief_summary>This study investigate safety pharmacokinetic comparison Pacific Pharma 's PP-101 SR ( test formulation ) Otsuka 's PletaalÂ® IR ( reference formulation ) single multiple dos food effect Pacific Pharma 's PP-101 SR healthy volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetic Comparison Cilostazol SR IR Formulations Healthy Korean Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Healthy male female volunteer age 19 55 within 20 % ideal body weight , without congenital abnormality chronic disease Female subject show positive result serum pregnancy test study , childbearing potential agree use one follow medically accept method contraception entire period study : abstinence , document tubal ligation least 1 year enrollment study , document placement intrauterine device proven failure rate &lt; 1 % per year , double barrier method ( spermicide plus male condom female diaphragm ) . History cardiovascular , pulmonary , renal , endogenous , gastrointestinal , hematologic , neurologic hemorrhagic disease ; Clinically significant finding routine laboratory ( hematology , serum chemistry urinalysis ) ECG test ; Use prescription drug 14 day immediately prior start study potential interact study medication ; Use substance could induce CYP3A4 synthesis ( eg , St. John 's wort , herbal medication ) .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>